Total Payments
$1,867
2024 Payments
$423.41
Companies
14
Transactions
60
Medicare Patients
11,525
Medicare Billing
$820,951
Payment Breakdown by Category
Food & Beverage$1,488 (79.7%)
Education$379.46 (20.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,488 | 54 | 79.7% |
| Education | $379.46 | 6 | 20.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $702.89 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $472.38 | 11 | $0 (2024) |
| Amgen Inc. | $164.75 | 4 | $0 (2023) |
| GENZYME CORPORATION | $112.59 | 7 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $103.10 | 2 | $0 (2019) |
| Celgene Corporation | $92.98 | 2 | $0 (2019) |
| Dermavant Sciences, Inc. | $50.66 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $41.52 | 2 | $0 (2023) |
| Arcutis Biotherapeutics, Inc. | $39.42 | 2 | $0 (2024) |
| PFIZER INC. | $30.54 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $423.41 | 11 | ABBVIE INC. ($262.82) |
| 2023 | $582.65 | 23 | AbbVie Inc. ($246.80) |
| 2022 | $147.83 | 9 | GENZYME CORPORATION ($66.79) |
| 2021 | $99.63 | 1 | Amgen Inc. ($99.63) |
| 2020 | $65.63 | 3 | AbbVie Inc. ($43.30) |
| 2019 | $455.93 | 12 | Janssen Biotech, Inc. ($119.98) |
| 2017 | $91.99 | 1 | Janssen Biotech, Inc. ($91.99) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $107.95 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.54 | General |
| Category: Immunology | ||||||
| 08/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 07/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Dermatology | ||||||
| 07/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $64.95 | General |
| Category: Immunology | ||||||
| 04/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.22 | General |
| Category: IMMUNOLOGY | ||||||
| 04/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $108.25 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Dermatology | ||||||
| 09/25/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.20 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Immunology | ||||||
| 09/07/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $85.91 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: Inflammation | ||||||
| 08/18/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: IMMUNOLOGY | ||||||
| 07/31/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: IMMUNOLOGY | ||||||
| 07/10/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: DERMATOLOGY | ||||||
| 05/22/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 05/15/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: IMMUNOLOGY | ||||||
| 05/11/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Inflammation | ||||||
| 05/08/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Immunology | ||||||
| 04/27/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Immunology | ||||||
| 04/26/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $101.14 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,715 | 4,512 | $593,385 | $194,796 |
| 2022 | 30 | 3,000 | 5,334 | $667,033 | $221,253 |
| 2021 | 28 | 3,047 | 5,510 | $643,856 | $227,104 |
| 2020 | 21 | 2,763 | 4,852 | $521,710 | $177,798 |
Total Patients
11,525
Total Services
20,208
Medicare Billing
$820,951
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 601 | 899 | $132,498 | $45,752 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 452 | 582 | $101,093 | $34,256 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 268 | 336 | $82,675 | $26,383 | 31.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 256 | 290 | $62,911 | $20,741 | 33.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 311 | 375 | $48,238 | $11,996 | 24.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 46 | 65 | $22,614 | $7,187 | 31.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 107 | 115 | $22,340 | $6,627 | 29.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 232 | 1,302 | $16,635 | $6,149 | 37.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 43 | 49 | $15,851 | $5,747 | 36.3% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 39 | 42 | $9,829 | $3,489 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $9,627 | $3,221 | 33.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 11 | 12 | $6,997 | $2,782 | 39.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 47 | 47 | $10,126 | $2,763 | 27.3% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 27 | $7,130 | $2,645 | 37.1% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 19 | $6,882 | $2,568 | 37.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 23 | 26 | $7,374 | $2,454 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 54 | 60 | $6,498 | $2,281 | 35.1% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 11 | 12 | $4,156 | $1,445 | 34.8% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 14 | 15 | $4,797 | $1,416 | 29.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 35 | 38 | $3,064 | $1,187 | 38.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 16 | 26 | $2,502 | $957.71 | 38.3% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 11 | 11 | $2,600 | $910.69 | 35.0% |
| 69100 | Biopsy of ear | Office | 2023 | 16 | 16 | $2,959 | $863.82 | 29.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 18 | 18 | $2,499 | $772.66 | 30.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 15 | $555.00 | $140.27 | 25.3% |
About Dr. Edward Smith, MD
Dr. Edward Smith, MD is a Dermatopathology healthcare provider based in High Point, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1679577100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Smith, MD has received a total of $1,867 in payments from pharmaceutical and medical device companies, with $423.41 received in 2024. These payments were reported across 60 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,488).
As a Medicare-enrolled provider, Smith has provided services to 11,525 Medicare beneficiaries, totaling 20,208 services with total Medicare billing of $820,951. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties Dermatology
- Location High Point, NC
- Active Since 06/13/2005
- Last Updated 06/03/2025
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1679577100
Products in Payments
- SKYRIZI (Biological) $346.93
- TREMFYA (Drug) $260.41
- Otezla (Drug) $257.73
- RINVOQ (Biological) $241.71
- DUPIXENT (Biological) $215.69
- Tremfya (Drug) $119.98
- Humira (Biological) $95.71
- STELARA (Biological) $91.99
- VTAMA (Drug) $50.66
- Zoryve (Drug) $39.42
- CIBINQO (Drug) $30.54
- COSENTYX (Biological) $22.33
- Ameluz (Drug) $21.47
- COSENTYX (Drug) $19.19
- Skyrizi (Biological) $18.54
- Sotyktu (Drug) $18.54
- ADBRY (Biological) $12.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.